NextPharma

NextPharma has appointed a new management team at its San Diego, CA facility. This new team at NextPharma will be responsible for the day-to-day management of the facility and for building the company’s presence in the U.S. through the further development of sterile manufacturing of investigational new products, diagnostics and devices, clinical trials labeling and packaging, and long term storage and distribution.

Ronald W. Collins has been appointed as interim general manager. Mr. Collins has many years of experience, including building up a steriles formulation development and fill-finish manufacturing business for clinical trials supply, running a global technology company, and serving as vice president of a Fortune 500 company.

Alan Sanders has been appointed director of finance. Mr. Sanders has 20 years of experience as a finance professional and operations director, including financial planning, analysis and reporting, demand planning, price setting, manufacturing costing, management controls, G/L maintenance, cash and risk management, SOX compliance, and operations management in a global environment.

Mary Richardson has been appointed director of quality. Mr. Richardson has many years of experience in QA and compliance management. She has 27 years of pharmaceutical and biotechnology experience and is licensed by the California State Board of Pharmacy. She is also an ASQ Certified Quality Engineer and Certified Quality Auditor.

Bruce Johnson was appointed director of operations. Mr. Johnson has 21 years of sterile pharmaceutical manufacturing and lyophilization experience and a track record with leadership, team building, and hands-on management skills in sterile biologics manufacturing and lyophilization.

Sean Marett, managing director of NextPharma Technologies, Product Development Services, commented: “We are delighted to have this team in place in San Diego. Collectively they bring a wealth of knowledge and experience in sterile manufacturing of investigational medical products and devices and we look forward to the future as they continue to establish NextPharma Technologies as a leading contract manufacturing provider in North America.”